Latest News

Heparin derivative suppresses neuroblastoma tumor growth

A new strategy for treating neuroblastoma using a modified version of heparin, a century-old injectable drug that thins the blood to prevent clots from forming, has been discovered by researchers. The study, conducted in mice, found that when heparin is altered to remove its blood-thinning properties, it can suppress and shrink neuroblastoma tumors without causing severe bleeding.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • With racial segregation declining between neighborhoods, segregation now taking new form

  • Gene variants modifying Huntington's symptom onset may lead to new therapeutic strategies

  • Prescription for medical students: A day at the art museum?

  • Aquariums deliver health and wellbeing benefits

  • Teaching med students about health disparities builds their confidence

  • Antibiotics increase risk of hearing loss in patients with deadly bacterial infections

  • Changing clocks, changing seasons: Scientists find role for neuronal plasticity

  • Genetic tug of war in the brain influences parental control over offspring behavior

  • Generally accepted tools used to select patients for aneurysm treatment in need of further evaluation

  • Analysis of post deployment health assessment forms indicates risks of alcohol abuse among service members returning from deployment

  •